Background: The severity of COVID 19 symptoms has a direct correlation with lymhpopenia,
affecting natural killer (NK) cells. SARS-CoV-2 specific “memory” NK cells obtained from …

Background: Adoptive cell immunotherapies for opportunistic virus in immunocompromised
patients using haploidentical memory T cells have shown to be safe and effective. Since …

Background Moderate/severe cases of COVID-19 present a dysregulated immune system
with T cell lymphopenia and a hyper-inflammatory state. This is a study protocol of an open …

COVID‐19 disease is the manifestation of syndrome coronavirus 2 (SARS‐CoV‐2) infection,
which is causing a worldwide pandemic. This disease can lead to multiple and different …

The global outbreak of coronavirus-2019 (COVID-19) still claims more lives daily around the
world due to the lack of a definitive treatment and the rapid tendency of virus to mutate …

Natural Killer (NK) cells are innate immune responders critical for viral clearance and
immunomodulation. Despite their vital role in viral infection, the contribution of NK cells in …

The emergence of novel respiratory viruses such as SARS-CoV-2 results in rapid
dissemination through virus-naive populations and an accumulation of critically ill patients in …

At the end of 2019, an outbreak of a severe respiratory disease occurred in Wuhan China,
and an increase in cases of unknown pneumonia was alerted. In January 2020, a new …

Natural killer (NK) cells contribute to early antiviral immunity, and in this preprint,
Maucourant et al. report reduced NK cell counts in the peripheral blood of 27 patients …

Abstract Coronavirus disease 2019 (COVID-19) is a novel infectious viral disease caused by
the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Two consecutively …